Pharmaron Beijing Co., Ltd. (SZSE: 300759)
Health Care · Life Sciences Tools & Services · CN
CN¥44.97
+3.38% today · +27.4% 1Y
Pharmaron Beijing Co., Ltd. (SZSE: 300759) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $11.36B and employs 27,316 people.
Over the last twelve months the share price has gained 27.4%, trading between 21.01 and 53.57.
Tweenvest scores Pharmaron Beijing Co., Ltd. across four factors: quality 68/100, value 43/100, growth 77/100, dividend 17/100. Its strongest factor is growth.
300759 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.36B
- Revenue (TTM)
- $2.24B
- P/E
- 47.31
- EPS
- 0.95
- Dividend yield
- 0.44%
- Beta (5Y)
- 0.68
- 52-week high
- CN¥53.57
- 52-week low
- CN¥21.01
- Avg volume (3M)
- —
- Shares outstanding
- 1.84B
- Employees
- 27,316
- Next earnings
- —
About Pharmaron Beijing Co., Ltd.
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
- ISIN
- CNE100003JW4
- Founded
- 2004
- Listed since
- Jan 28, 2019
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Genscript Biotech CorporationSEHK: 1548 | $12.71B | HK$43.72 | +1.82% |
| Tempus AI, Inc.NasdaqGS: TEM | $12.69B | $69.28 | -1.52% |
| ICON Public Limited CompanyNasdaqGS: ICLR | $12.66B | $164.50 | +0.26% |
| Bio-Techne CorporationNasdaqGS: TECH | $11.37B | $72.45 | -0.11% |
| Avantor, Inc.NYSE: AVTR | $10.38B | $15.39 | +0.26% |
| 10x Genomics, Inc.NasdaqGS: TXG | $9.92B | $77.28 | +1.55% |
| Bio-Rad Laboratories, Inc.NYSE: BIO | $9.82B | $360.40 | -2.04% |
| Repligen CorporationNasdaqGS: RGEN | $9.44B | $163.84 | -2.02% |
Figures last refreshed Oct 4, 2026.